Intercept Pharmaceuticals (ICPT) PT Raised to $187 at Raymond James
Tweet Send to a Friend
Raymond James analyst Steven Seedhouse raised the price target on Intercept Pharmaceuticals (NASDAQ: ICPT) to $187.00 (from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
